Back to Drug Index
EGYPTIAN PHARMACEUTICAL DIRECTORY

PHENYTOIN-AIT TOPICAL SPRAY 150 ML

OFFICIAL RETAIL PRICE EGP 63.00
Active Molecule
PHENYTOIN
Form & Route
Spray
Manufacturer
EGYPTIAN CO. FOR ADV. PHARMA. (ECAP) > ACDIMA INTERNATIONAL TRADING
Therapeutic Class
SKIN CARE.HEALING
Cost-Saving Equivalent Available: You can save up to EGP 61.00 by switching to PHAROTOIN 50MG 10 CAPS. (EGP 2.00).
Commercial brands in Egypt sharing the exact same active molecule & dosage form.
Oral Solid (Tablets / Capsules) • EL NILE. > PFIZER
EGP 14.40 Saves EGP 48.60
Injection (Vial / Ampoule) • MUP
EGP 50.00 Saves EGP 13.00
Topical (Cream / Ointment) • UNIPHARMA CO. > AL HADIDI PHARMA
EGP 33.00 Saves EGP 30.00
Spray • EGYPTIAN CO. FOR ADV. PHARMA. (ECAP) > ACDIMA INTERNATIONAL TRADING
EGP 87.00 +EGP 24.00
Oral Solid (Tablets / Capsules) • ARAB CAPS > ACDIMA INTERNATIONAL TRADING
EGP 51.00 Saves EGP 12.00
Oral Liquid (Syrup / Suspension) • T3A PHARMA > ACDIMA INTERNATIONAL TRADING
EGP 13.50 Saves EGP 49.50
Oral Solid (Tablets / Capsules) • ARAB CAPS > ACDIMA INTERNATIONAL TRADING
EGP 35.00 Saves EGP 28.00
Oral Solid (Tablets / Capsules) • PHAROPHARMA
EGP 2.00 Saves EGP 61.00
Injection (Vial / Ampoule) • ALEXANDRIA > EGYPHARMA-EGYPT
EGP 37.50 Saves EGP 25.50
Oral Solid (Tablets / Capsules) • EL NILE.
EGP 51.00 Saves EGP 12.00
Injection (Vial / Ampoule) • EL NILE.
EGP 11.00 Saves EGP 52.00
Injection (Vial / Ampoule) • EL NILE.
EGP 110.00 +EGP 47.00
Injection (Vial / Ampoule) • EL NILE.
EGP 110.00 +EGP 47.00
Oral Liquid (Syrup / Suspension) • EL NILE.
EGP 19.00 Saves EGP 44.00
Oral Solid (Tablets / Capsules) • EL NILE.
EGP 32.00 Saves EGP 31.00
Oral Solid (Tablets / Capsules) • EL NASR
EGP 16.00 Saves EGP 47.00
Oral Solid (Tablets / Capsules) • EL NASR
EGP 13.50 Saves EGP 49.50
Injection (Vial / Ampoule) • SABEX INC.-CANADA > INCO PHARMA-EGYPT
EGP 90.00 +EGP 27.00
Verified Directory Notice: Official retail pricing and commercial specifications reflect Egyptian MOH/EDA registered records. Always consult a licensed healthcare professional or pharmacist prior to modifying or substituting prescription drug treatments.

System Notice

Confirm Action